CREOPM™ is a novel portfolio management framework that improves decision-making under risk and uncertainty. To complement this framework. a portfolio management capability maturity model assessment is proposed. This workshop will enable participants to approach portfolio management in a systematic, holistic, and analytically sound manner to enable portfolio decision-making in the context of an organization's business and strategic goals. Specifically, while portfolio selection across much of the pharma and biotech industry has been traditionally achieved through one form or another of project ranking and selection, the prescribed framework focuses on portfolio optimization in the context of the organization's constrained budgetary and human resources. Due to workshop format, seating will be limited and will be available on a first come, first served basis. The Pennsylvania Convention Center has stringent regulations on maximum room capacities, and they are strictly enforced. Once all seats are occupied, DIA will be required to close the workshop, and no more participants will be admitted. Interested attendees are encouraged to arrive at workshops early in order to ensure seating. Please note, as a workshop with interactivity, this event will not be recorded.

Learning Objectives:
Distinguish between non-discretionary and discretionary project investments
Explain how to conduct defensible risk analyses and evaluate projects with uncertain commercial value
Discuss how to optimize portfolios, and prioritize and manage projects successfully.